Related Experiment Video
Updated: Sep 21, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Drug-associated "bite cell" hemolytic anemia
1Department of Medicine, Providence Hospital, Washington, D.C.
Purpose:
"Bite cell" hemolytic anemia is a variant of drug-related hemolysis usually associated with methemoglobinemia and Heinz body inclusions in red blood cells secondary to oxidant drug injury. Bite cells are morphologically characterized as poikilocytes with one or more semicircular portions removed from the cell margin. The purpose of this report is to emphasize the importance of peripheral smear examination in patients with possible drug-associated hemolytic anemia. The morphologic characteristics of bite cells by light microscopy and scanning electron microscopy are detailed in this study, and the pathophysiologic mechanism is discussed.
Patients And Methods:
Clinical and laboratory data were retrospectively studied on eight patients (two men and six women, aged 29 to 85 years) who showed evidence of bite cell hemolytic anemia associated with drug exposure. Multiple standard hematologic laboratory evaluations for hemolytic anemia were performed. Five hundred red blood cells were counted from randomly selected peripheral smear fields for the calculation of bite cell percentage.
Results:
Peripheral smears showed predominantly normochromic normocytic red cells with prominent bite cells and occasional blister cells. Bite cell counts ranged from 5.5% to 13.6% (mean, 8.7 +/- 3.0% SD) associated with a hematocrit reduction of 3.0% to 13.2% (mean, 8.5 +/- 3.8% SD) and concomitant reticulocytosis of varying degree from 2.3% to 15.4% (mean, 7.3 +/- 4.9% SD). Withdrawal of the offending drug(s) and treatment of underlying diseases resulted in improvement of hemolytic anemia and eventual disappearance of bite cells. A close correlation between hematocrit reduction, reticulocyte response, and bite cell percentage increase was seen. The usual biochemical markers of hemolysis were not consistently observed. Scanning electron microscopy confirmed the light microscopic evidence of bite cell morphology and revealed a keratocytic variant.
Conclusion:
This study emphasizes the importance of peripheral smear examination for early diagnosis and management of bite cell hemolytic anemia. Withdrawal of the putative offending drug(s) and treatment of underlying disorders should result in improvement of this form of drug-associated hemolysis.
Insights
Peripheral smear examination is crucial for diagnosing drug-induced hemolytic anemia. Identifying bite cells and removing the offending drug leads to recovery.
Area of Science:
- Hematology
- Pathology
- Toxicology
Background:
- Drug-induced hemolytic anemia is often linked to methemoglobinemia and Heinz bodies.
- Bite cells, a type of poikilocyte, are characterized by semicircular cell margin defects.
- Oxidant drug injury can cause these morphological changes in red blood cells.
Purpose of the Study:
- To highlight the diagnostic significance of peripheral smear examination in drug-associated hemolytic anemia.
- To detail the morphological characteristics of bite cells using light and scanning electron microscopy.
- To discuss the pathophysiological mechanisms underlying bite cell formation.
Main Methods:
- Retrospective analysis of clinical and laboratory data from eight patients with bite cell hemolytic anemia.
- Standard hematologic evaluations for hemolytic anemia were performed.
- Bite cell percentage was calculated by examining 500 red blood cells per smear.
Main Results:
- Peripheral smears revealed bite cells (5.5%–13.6%) and occasional blister cells.
- Hematocrit reduction (3.0%–13.2%) and reticulocytosis (2.3%–15.4%) were observed.
- Drug withdrawal and treatment led to improvement and disappearance of bite cells, with a correlation between bite cell percentage and hemolysis markers.
Conclusions:
- Peripheral smear examination is vital for early diagnosis and management of bite cell hemolytic anemia.
- Discontinuing the causative drug and treating underlying conditions improves this hemolytic anemia.
- Morphological identification of bite cells aids in managing drug-induced red blood cell injury.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Rocky Mountain Spotted Fever
Rabies
Malaria
American Trypanosomiasis
Hypersensitivity Reactions: Immune-Complex Reactions

